Efficacy and safety of telitacicept in IgA nephropathy: a real-world study
Background IgA nephropathy (IgAN) is the most common primary glomerular disease in the world, and specific therapeutic methods for IgAN are limited. Telitacicept is a humanized fusion protein composed of a transmembrane activator and calcium-modulating cyclophilin ligand interactor receptor and huma...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Taylor & Francis Group
2025-12-01
|
| Seri Bilgileri: | Renal Failure |
| Konular: | |
| Online Erişim: | https://www.tandfonline.com/doi/10.1080/0886022X.2025.2449580 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|